Ekspresi Imunohistokimia Aktivitas Sel Natural Killer Dengan Cd107a Pada Endometrium Ektopik Penderita Endometriosis Dibandingkan Dengan Endometrium Normal
DAFTAR PUSTAKA
1. Eskenzi B, Warmer ML. Epidemiology of endometriosis. Obstet Gynecol
Clin North Am.1997; 24;235-58.
2. Jeung IH, Chung YJ, Chae B, et al. Effect of Helixor A on Natural Killer
Cell Activity in Endometriosis. Int.J Med.Sci, 2015; 12(1):42-47.
3. Siregar HS. L-Selectin P213S Polymorphism and Macrophage Profils in
Endometriosis;
an
new
insight
into
the
Pathophysiology
of
Endometriosis. Approved by Medan, Univ. of Sumatra Utara. 2014,
Lambert Academic Publishing, Schaltungsdients Lange o.H.G., Berlin.
P;9-63.
4. Simoens S, Dunselman G, Dirksen C, et al. The burden of
endometriosis: costs and quality of life of women with endometriosis
and treated in referral centres. Hum Reprod, 2012; 27;1292–9.
5. Bedaiwy, MA, Falcone T. Peritoneal fluid environment in endometriosis,
clinicopatological implication. Minerva Ginecology, 2003; 55;1-13.
6. Sampson JA. Peritoneal endometriosis due to menstrual dissemination
of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol,
1997; 14;422–69.
7. Wu MY, Yang JH, Ching YU, et al. Increase in the expression of killer
cell inhibitory receptors on peritoneal natural killer cells society for
reproductive medicine.Elsevier Science Inc. 2000; Vol;74, No;6.
8. IL-2 signaling and its primary biological effect in different immune cell.
http://www.rndsystems.com/Pathway.aspx?p=15455&r=15436.
94
9. Gaffen SL, Liu KD. Overview of Interleukin-2 Function, Production and
clinical applications. Elsevier Ltd. Cytokine, 2004; 28;109-23.
10. Alter G, Malenfant JM, Altfeld M. CD107a as a Functional Marker for
the Identification of Natural Killer Cell Activity. J of Immunological
Methods, 2004; 294;15-22.
11. Oosterlynck DJ, Meuleman C, Waer M, et al. Immunosupressive
Activity of Peritoneal Fluid in Women With Endometriosis. Obstet
Gynecol, 1993; 82;206-12.
12. Gagne D, Rivard M, Page M, et al. Blood Leukocyte Subset are
Modulated in Patients With Endometriosis. Fertility and Sterility, 2003;
Vol;80, No;1.
13. Djaganata SP. Ekspresi Imunohistokimia Sel Natural Killer Pada
Endometrium Ektopik Penderita Endometriosis. Tesis Spesialis Obgin
FK USU, 2015.
14. Ahn SY, Monsanto SP, Caragh M, et al. Pathophysiology and immune
dysfungtion in endometriosis.biomed reserch international article ID
795976, 2003.
15. Agarwal A. Role of oxidative stress in endometriosis. Reproductive
BioMedicine Online. 2006; 13(1);126–34.
16. Dmowski WP, Ding J, Shen J, et al. Apoptosis in endometrial glandular
and stromal cells in women with and without endometriosis. Human
Reproduction. 2001; 16;1802–8.
95
17. D’Hooghe TM, Bambra CS, Raeymaekers BM, et al. The effects of
immunosuppression on development and progression of endometriosis
in baboons (Papio
nubis). Fertility and Sterility. 1995; 64; 172–8.
18. Sharpe-Timms KL. Basic research in endometriosis. Obstetrics and
Gynecology Clinics of North America. 1997; 24;269–90.
19. Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of
endometrium
reveals
progesterone
resistance
and
candidate
susceptibility genes in women with endometriosis. Endocrinology. 2007;
148;3814–26.
20. Kwak JY, Beaman KD, Gilman-Sachs A, et al. Up regulated expression
of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood
lymphocytes in pregnant women with recurrent pregnancy losses. Am.J.
Reprod. Immunol. 1995 ; 34 ;93-99.
21. Falcone T, Lebovic DI. Clinical Management of Endometriosis. Obstet &
Gynecol, Sep 2011; 118(3);691-705.
22. Nurhuda.
Jaringan
Endometrium
Perempuan
Infertil
Secara
Imunohistokimia. Maj.Kedokteran Indon. 2007; Vol(57), No;11, Hal;
385-90.
23. Houston DE, Noller KL, Melton LJ, et al. The epidemiology of pelvic
endometriosis. Clinical Obstetrics and Gynecology. 1998; (31); 787–
800.
96
24. Gruppo Italiano per lo studio dell’endometriosis. Prevalence and
anatomical distribution of endometriosis in women with selected
gynaecological conditions; results from a multicentric Italian study.
Human Reproduction. 1994; (9);1158–62.
25. Neme RM, Andrade DC, Brescia M, et al. Epidemiological study on risk
factors of pelvic endometriosis in Brazil. Fertility and Sterility. 2002;
(77);537.
26. Meiling H, Lingya PL, Baozhen W, et al. A case-control epidemiologic
study of endometriosis. Chinese Medical Science Journal. 1994;
(9);114–18.
27. Candiani GB, Parazzini F, Danesino V, et al. Reproductive and
menstrual factors and risk of peritoneal and ovarian endometriosis.
Fertility and Sterility. 1991; (56);230–34.
28. Maybin JA, Critchley HO. Progesterone: a pivotal hormone at
menstruation. Ann NY Acad Sci, 2011; 1221;88-97.
29. Carlino C, Stabile H, Morrone S, et al. Recruitment of circulating NK
cells through decidual tissues; a possible mechanism controlling NK cell
accumulation in the uterus during early pregnancy. Blood, 2008;
111;3108-15.
30. King AE, Critchley HO. Oestrogen and progesterone regulation of
inflammatory processes in the human endometrium. J Steroid Biochem
Mol Biol, 2010; 120;116-126.
97
31. Hanna J, Goldman WD, Hamani Y, et al. Decidual NK cells regulated
key developmental processes at the human fetal-maternal interface.
Nat Med, 2006; 12;1065-74.
32. David DZ, Aplin AC, and Nicosia RF. Regulation of angiogenesis by
macrophages, dendritic cells, and circulating myelomonocytic cells.
Curr Pharm Des.,2009; 15;365-79.
33. Siamatupang J. Perubahan Imunologis Pada Endometriosis Peritoneal.
Departemen Obgin Universitas Sriwijaya, 2003; Ref(4);1-19.
34. Bedaway MA, Falcone T, Sharma RR, et al. Prediction of endometriosis
with serum and peritoneal fluid markers: a prospective controlled trial.
Hum Reprod, 2002; 75;1-10.
35. Keenan JA, Chen TT, Chadwell NL, et al. IL-1 beta, TNF-alpha, and IL2 in peritoneal fluid and macrophade –conditioned media of women with
endometrioais. Am J Reprod Immunol, 1995; 34;381-5.
36. Tseng JF, Ryan JP, Milam TD, et al. Interleukin-6 secretion in vitro is
upcells from women with endometriosis. J Clin Endocrinol Metab, 1996;
81;1118-22.
37. Patrono C. Arachdoic acid metabolism in the ovary; biochemistry,
methodology, and physiologi. In Serra B (ed). Comprehensive
Endocrinology. The Ovary, New York:raven press, 1983; 45-56.
38. Bartosik D. Immunologic aspects of endometriosis. Seminars in
reproductive Endocrinology, 1985; 299-337.
98
39. Oosterlynck DJ, Cornillie FJ, Waer M, et al.
Immunohistochemical
characterization of leucocyte subpopulations in endometriotic lesions.
Arch Gynecol Obstet, 1993; 253;197–206.
40. Rosevear SK. Handbooks of Gynaecology Management. Endometriosis
and Chronic Pelvic Pain, Blackwell Science Ltd. Chapter, 2002; 11;2505.
41. Mclaren J, Prentice A, Charnock JD, et al. Vascular Endothelial Growth
Factor (VEGF) Concentration are Elevated in Peritoneal Fluid of
Women with Endometriosis. Hum Rep, 1996; 11:220-3.
42. Gibbs
RS,
Karlan
BY.
Danforths
Obstetrics
and
Gynecology,
Endometriosis. Lippincott Williams & Wilkins. Tenth Edition, Chapter,
2008; 41;300-50.
43. Beckmann CR, Ling FW, Barzansky BM. Obstetrics and Gynecology.
Endometriosis. Lippincott Williams & Wilkins. Sixth Edition. 2010;
Chapter (29);120-80.
44. Ilie I, Ilie R. Cytokines and endometriosis- The role of Immunological
Alterations. Biotechnology, Moleculer Biology and Nanomedicine.
Desember 2013; Vol(1);2.
45. Funamizu A, Fukui A, et al. Expression of natural Cytotoxicity receptors
on peritoneal fluid natural killer cell and cytokine production by
peritoneal fluid natural killer cell in women with endometriosis. Dept.
Obgyn, Hirosaki Univ. Graduate School of Medicine, Hirosaki, Aomari,
Japan. American Journal of Reproductive Immunology. 2014; 71;35967.
99
46. David Dong ZM, Aplin AC, and Nicosia RF. Regulation of angiogenesis
by macrophages, dendritic cells, and circulating myelomonocytic cells.
Curr Pharm Des 2009; 15;365-79.
47. Ferdazzo G, Pack M, Thomas D, et al. Distinct roles of IL-12 and IL-15
in human natural killer cell activation by dendritic cells from secondary
lymphoid organs. Proc Natl AcadSci USA, 2004; 101(47);16606-11.
48. Moretta A, Bottino C, Vitale M, et al. Activating receptors and
coreceptorrs involved in human natural killer cell-mediated cytolysis.
Annu Rev Immunol, 2001;19;197-223.
49. Van den HM, Bashar S,Junkina ME, et al. Functional adhesion of CD56
cells to decidual endothelium predicts pregnancy success in vitro
fertilization. Montreal, Canada : Paper presented at:12th International
Congress of Immunology and 4th Annual Conference of FOCIS, 2004.
50. King A. Uterine leucocytes and decidualization. Hum Reprod Update,
2006; 6(1);28-36.
51. Knopman LA, Kopcow HD, Rybalov B, et al. Human decidual natural
killer cells are a unique NK cell subset with immunomodulatory
potential. J Exp Med, 2003; 198(8);1201-12.
52. Henderson RA, Saunders PT, Mofett-King A, et al. Steroid receptor
expression in uterine natural killer cells. J Clin Endocrinol Metab, 2003;
88(1);440-49.
53. Craig A, and Witz MD. Interleukin-6; another piece of the endometriosis
cytokine puzzle. Fertility and Sterility, 2000; 73(2);212-14.
100
54. Danudjo T.
Analisis Komparasi dan
Peran
Interleukin-6
serta
Interleukin-8 dalam Zalir Peritoneal Penderita Infertilitas disertai
Endometriosis dalam Proses Apoptosis Sel Granulosa Ovarii yang
Patologis. [Disertasi]. Surabaya: Universitas Airlangga, 2003.
55. Bedaiwy MA, and Falcone T. Peritoneal fluid environment in
endometriosis, clinicopatological implication. Minerva Ginecology, 2003;
55;1-13.
56. Herington JL, Bruner KL. Immune Interaction in endometriosis expert
Rev. Clin Immunol. September 2011; 7(5);611-26.
57. Attar E. Current concepts and research in the pathogenesis of
endometriosis. 1999. Endometriosis Zone. www.OBGYN.net.com.
58. Bruner KL, Herington JL. Medical Management of endometriosis :
Emerging evidence linking inflamation to disease pathophysiology. NIH
Public Access, Minerva Ginecol, 2014; 65(2);199-213.
59. Maeda N, Izumiya C, et al. Killer Inhibitory Receptor CD158a
overexpression among natural killer cell in women with endometriosis is
undiminished by Laparoscopic Surgery and Gonadotropin releasing
hormone agonist Treatment. American Journal of Reproductive
Immunology, 2004; 51;364-72.
60. Eidukaite A., Siaurys A., Tamosiunas V. Aberrant Expression of CD 95
and CD 69 Molecules among CD 56+ Cells in Women with
Endometriosis. American Journal of Reproductive immunology; 2006;
No;55, pp;276-81.
101
61. Ahn SH, Monsanto SP, et al. Pathophysiology and Immune dysfunction
in endometriosis. Dept. Of Biomedical and Moleculer Sciences, Queen
Unv. Kingston, Biomed Research International, 2014.
62. Matsuoka S, Maeda N, et al. Expression of Inhibitory-Motif Killer
Immunoglobulin-Like Receptor, KIR2DL1, is Increased in Natural Killer
Cells from Women with Pelvic Endometriosis. American Journal of
Reproductive Immunology, 2005; Vol(53p);249-54.
63. Kim CM, Oh YJ, Cho SH, et al. Increased telomerase activity and
human telomerase reverse transcriptase mRNA expression in the
endometrium of patients with endometriosis.Hum Reprod,2007;22;8439.
64. Quenby S, Bates M, Vince G, et al. Immunohistochemical investigation
of leukocytes in pre-implantation endometrium of women with recurrent
miscarriage. J.Soc. Gynecol Invest, 1999; 6;Abstr;664.
65. Darya
HR.
Perbedaan
Kadar
IL-2
Pada
Wanita
Penderita
Endometriosis dan Non Endometriosis. Tesis Magister Obgin FK USU,
2014.
66. Laird SM, Mariee N, Wei L. Et al. Measurement of CD 56+ cells in
peripheral
blood
and
endometrium
by
flow
cytometry
and
immunohistochemical staining in situ. Human Reproduction, 2011:
Vol;26; No;6 pp;1331-7.
67. Dahlan MS. Besar sampel Dan Cara Pengambilan Sampel, dalam
Penelitian Kedokteran dan Kesehatan. Salemba Medika, 2010;
Edisi(3);19-22.
102
68. Qureshi A, Pervez S. Alred Scoring for ER Reportingand It’s Impact in
Clearly Distinguishing ER Negative From ER Positive Breast Cancer.
Department of Pathology and Laboratory Medicine: The Aga Khan
University. Journal Pakistan Medical Association, 2010; 60(5);350-53.
69. Lanier L. Natutal Killer cel Receptor signalling. Department of
Microbiology and Immunology and the cancer Research Institute.
Current opinion in Immunology, 2003; 15;308-14.
70. Orange JS, Ballas ZK. Natural Killer cells in human health and disease,
Clin Immunol, 2006; 118;1-10.
71. Disanto JP. Natural Killer cells developmental pathways: a question of
balance, Annu. Rev.Immunol, 2006; 24;257-86.
72. Lanier LL. Natural Killer cell receptor signalling, Curr.Opin. Immunol,
2006; 15;304-14.
73. Cooper MA, Fehninger TA, Turner SC, et al. Human natural killer cells:
a unique innate immunoregulatory role for the CD56 (bright) subset,
2001; Blood 97;3146-51.
74. Dorner BG, Smith HR, French AR, et al. Coordinate expression of
cytokines and chemokines by NK cells during murine cytomegalovirus
infection, J. Immunol, 2004; 172;3119-31.
75. Loza ML, Zamai L, Azzoni L, et al. Expression of type 1 (interferon
gamma) and type 2 (interleukin-13, interleukin-5) cytokine at distinct
stages of natural killer cell differentiation from progenitor cells, 2002;
Blood 99;1273-81.
103
76. Robertson MJ. Role of chemokines in the biology of natural killer
cells,J.leukoc.Biol, 2002; 71;173-83.
77. Peters PJ, Borst J, Oorschot V, et al. Cytotoxic T lymphocyte granules
are secretory lysosomes,containing both perforin and granzymes, J.
Exp. Med, 1991; 173;1099–109.
78. Winchester BG. Lysosomal membrane proteins, Eur. J. Paediatr.
Neurol. 2001; 5;11–19.
79. Fukuda
M.
Lysosomal
membrane
glycoproteins.
Structure,
biosynthesis, and intracellular trafficking, J. Biol. Chem, 1991;
266;21327–330.
80. Kannan K, Stewart RM, Bounds W, et al. Lysosome-associated
membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are
activation-dependent cell surface glycoproteins in human peripheral
blood mononuclear cells which mediate cell adhesion to vascular
endothelium, Cell. Immunol, 1996; 171;10–19.
81. Konrad KA. Lamp 1/CD107a is required for effient perforin delivery to
lytic granules and NK-cell Cytotoxyty. 2013; Blood;121.
82. Meyer C, Zizioli D, Lausmann S, et al. Mu1A adaptin-deficient mice:
lethality,
loss
of
AP-1binding
and
rerouting
of
mannose
6-
phosphatereceptors. EMBO J, 2000; 19(10);2193-203.
83. Delevoye C, Hurbain I, Tenza D, et al. AP-1 and KIF13A coordinate
endosomal sorting andpositioning during melanosome biogenesis. J
CellBiol, 2009; 187(2);247-64.
104
84. Nakagawa T, Setou M, Seog D, et al. A novelmotor, KIF13A, transports
mannose-6-phosphatereceptor
to
plasma
membrane
through
directinteraction with AP-1 complex. Cell, 2000; 103(4);569-81.
85. Bryceson YT, Rudd E, Zheng C, et al. Defectivecytotoxic lymphocyte
degranulation
in
syntaxin-11
deficient
familial
hemophagocytic
lymphohistiocytosis 4 (FHL4) patients. 2007; Blood.110(6);1906-15.
86. Ishii E, Ueda I, Shirakawa R, et al. Genetic subtypes of familial
hemophagocytic lymphohistiocytosis: correlations with clinical features
and cytotoxic T lymphocyte/natural killer cell functions. Blood. 1995;
105(9);3442-48.
87. Keefe D, Shi L, Feske S, et al. Perforin triggers a plasma membranerepair response that facilitates CTL induction of apoptosis. Immunity,
2005; 23(3);249-62.
88. Thiery J, Keefe D, Boulant S, et al. Perforin pores in the endosomal
membrane trigger the release of endocytosed granzyme B into the
cytosol of target cells. Nat Immunol, 2011; 12(8);770-77.
89. Portales P, Reynes J, Pinet V, et al. Interferonalpha restores HIVinduced alteration of naturalkiller cell perforin expression in vivo. AIDS,
2003; 17(4);495-504.
90. Rak GD, Mace EM, Banerjee PP, et al. Natural killer cell lytic granule
secretion occurs through a pervasive actin network at the immune
synapse. PloS Biol, 2011; 9(9);e1001-151.
105
91. Liu D, Martina JA, Wu XS, Hammer JA III, Long EO. Two modes of lytic
granule fusion during degranulation by natural killer cells. Immunol Cell
Biol. 2011; 89(6);728-38.
92. Moretta L, Christina B, Daniela P, et al. Human natural killer cells; their
origin,receptors and function. Eur J Immunol, 2002; 32;1205-11.
93. Oosterlynck DJ, Meuleman C, Waer M, et al. The natural killer activity
of
peritoneal fluid
lymphocytes
is
decreased
in
women
with
endometriosis. Fertil Steril, 1992; 58;290-95.
94. Vigano P, Vercellini P, Blasio D, et al. Deficient antiendometrium
lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil
Steril, 1991; 56;894-99.
95. Oosterlynck DJ, Meuleman C, Waer M, et al. The natural killer activity
of
peritoneal fluid
lymphocytes
is
decreased
in
women
with
endometriosis. Fertil Steril, 1992; 58;290-95.
96. Wilson TJ, Hertzog PJ, Angus D, et al. Decreased natural killer cell
activity in endometriosis patients:relationship to disease pathogenesis.
Fertil Steril, 1994; 62;1086-88.
97. Ho-hong N, Kuang-han C, Hsin Fu C. Peritoneal natural killer cytotoxity
and CD25+ CD3+ lymphocyte subpopulation are decreased in woman
with stage III-IV endometriosis. Human Rep, 1995; Vol;10, No;10,
pp;2671-75.
106
98. Simigliana E, Pvigano, Gaffuri B, et al. Modulation Of NK cell lytic
fuction by endometrial secretory factors:protential role in endometriosis,
American journal of reproductive immunology, 1996; Vol;36, No:5,
pp;295-300.
99. Ho HN, chao KH, Chen CH, et al. Peritoneal natural killer cytotoxity and
CD25+ CD3+ lymphocyte subpopulation are decreased in woman with
stage III-IV endometriosis. Human reprodution, 1995; Vol;10, No; 10,
pp;2671-75.
107
1. Eskenzi B, Warmer ML. Epidemiology of endometriosis. Obstet Gynecol
Clin North Am.1997; 24;235-58.
2. Jeung IH, Chung YJ, Chae B, et al. Effect of Helixor A on Natural Killer
Cell Activity in Endometriosis. Int.J Med.Sci, 2015; 12(1):42-47.
3. Siregar HS. L-Selectin P213S Polymorphism and Macrophage Profils in
Endometriosis;
an
new
insight
into
the
Pathophysiology
of
Endometriosis. Approved by Medan, Univ. of Sumatra Utara. 2014,
Lambert Academic Publishing, Schaltungsdients Lange o.H.G., Berlin.
P;9-63.
4. Simoens S, Dunselman G, Dirksen C, et al. The burden of
endometriosis: costs and quality of life of women with endometriosis
and treated in referral centres. Hum Reprod, 2012; 27;1292–9.
5. Bedaiwy, MA, Falcone T. Peritoneal fluid environment in endometriosis,
clinicopatological implication. Minerva Ginecology, 2003; 55;1-13.
6. Sampson JA. Peritoneal endometriosis due to menstrual dissemination
of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol,
1997; 14;422–69.
7. Wu MY, Yang JH, Ching YU, et al. Increase in the expression of killer
cell inhibitory receptors on peritoneal natural killer cells society for
reproductive medicine.Elsevier Science Inc. 2000; Vol;74, No;6.
8. IL-2 signaling and its primary biological effect in different immune cell.
http://www.rndsystems.com/Pathway.aspx?p=15455&r=15436.
94
9. Gaffen SL, Liu KD. Overview of Interleukin-2 Function, Production and
clinical applications. Elsevier Ltd. Cytokine, 2004; 28;109-23.
10. Alter G, Malenfant JM, Altfeld M. CD107a as a Functional Marker for
the Identification of Natural Killer Cell Activity. J of Immunological
Methods, 2004; 294;15-22.
11. Oosterlynck DJ, Meuleman C, Waer M, et al. Immunosupressive
Activity of Peritoneal Fluid in Women With Endometriosis. Obstet
Gynecol, 1993; 82;206-12.
12. Gagne D, Rivard M, Page M, et al. Blood Leukocyte Subset are
Modulated in Patients With Endometriosis. Fertility and Sterility, 2003;
Vol;80, No;1.
13. Djaganata SP. Ekspresi Imunohistokimia Sel Natural Killer Pada
Endometrium Ektopik Penderita Endometriosis. Tesis Spesialis Obgin
FK USU, 2015.
14. Ahn SY, Monsanto SP, Caragh M, et al. Pathophysiology and immune
dysfungtion in endometriosis.biomed reserch international article ID
795976, 2003.
15. Agarwal A. Role of oxidative stress in endometriosis. Reproductive
BioMedicine Online. 2006; 13(1);126–34.
16. Dmowski WP, Ding J, Shen J, et al. Apoptosis in endometrial glandular
and stromal cells in women with and without endometriosis. Human
Reproduction. 2001; 16;1802–8.
95
17. D’Hooghe TM, Bambra CS, Raeymaekers BM, et al. The effects of
immunosuppression on development and progression of endometriosis
in baboons (Papio
nubis). Fertility and Sterility. 1995; 64; 172–8.
18. Sharpe-Timms KL. Basic research in endometriosis. Obstetrics and
Gynecology Clinics of North America. 1997; 24;269–90.
19. Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of
endometrium
reveals
progesterone
resistance
and
candidate
susceptibility genes in women with endometriosis. Endocrinology. 2007;
148;3814–26.
20. Kwak JY, Beaman KD, Gilman-Sachs A, et al. Up regulated expression
of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood
lymphocytes in pregnant women with recurrent pregnancy losses. Am.J.
Reprod. Immunol. 1995 ; 34 ;93-99.
21. Falcone T, Lebovic DI. Clinical Management of Endometriosis. Obstet &
Gynecol, Sep 2011; 118(3);691-705.
22. Nurhuda.
Jaringan
Endometrium
Perempuan
Infertil
Secara
Imunohistokimia. Maj.Kedokteran Indon. 2007; Vol(57), No;11, Hal;
385-90.
23. Houston DE, Noller KL, Melton LJ, et al. The epidemiology of pelvic
endometriosis. Clinical Obstetrics and Gynecology. 1998; (31); 787–
800.
96
24. Gruppo Italiano per lo studio dell’endometriosis. Prevalence and
anatomical distribution of endometriosis in women with selected
gynaecological conditions; results from a multicentric Italian study.
Human Reproduction. 1994; (9);1158–62.
25. Neme RM, Andrade DC, Brescia M, et al. Epidemiological study on risk
factors of pelvic endometriosis in Brazil. Fertility and Sterility. 2002;
(77);537.
26. Meiling H, Lingya PL, Baozhen W, et al. A case-control epidemiologic
study of endometriosis. Chinese Medical Science Journal. 1994;
(9);114–18.
27. Candiani GB, Parazzini F, Danesino V, et al. Reproductive and
menstrual factors and risk of peritoneal and ovarian endometriosis.
Fertility and Sterility. 1991; (56);230–34.
28. Maybin JA, Critchley HO. Progesterone: a pivotal hormone at
menstruation. Ann NY Acad Sci, 2011; 1221;88-97.
29. Carlino C, Stabile H, Morrone S, et al. Recruitment of circulating NK
cells through decidual tissues; a possible mechanism controlling NK cell
accumulation in the uterus during early pregnancy. Blood, 2008;
111;3108-15.
30. King AE, Critchley HO. Oestrogen and progesterone regulation of
inflammatory processes in the human endometrium. J Steroid Biochem
Mol Biol, 2010; 120;116-126.
97
31. Hanna J, Goldman WD, Hamani Y, et al. Decidual NK cells regulated
key developmental processes at the human fetal-maternal interface.
Nat Med, 2006; 12;1065-74.
32. David DZ, Aplin AC, and Nicosia RF. Regulation of angiogenesis by
macrophages, dendritic cells, and circulating myelomonocytic cells.
Curr Pharm Des.,2009; 15;365-79.
33. Siamatupang J. Perubahan Imunologis Pada Endometriosis Peritoneal.
Departemen Obgin Universitas Sriwijaya, 2003; Ref(4);1-19.
34. Bedaway MA, Falcone T, Sharma RR, et al. Prediction of endometriosis
with serum and peritoneal fluid markers: a prospective controlled trial.
Hum Reprod, 2002; 75;1-10.
35. Keenan JA, Chen TT, Chadwell NL, et al. IL-1 beta, TNF-alpha, and IL2 in peritoneal fluid and macrophade –conditioned media of women with
endometrioais. Am J Reprod Immunol, 1995; 34;381-5.
36. Tseng JF, Ryan JP, Milam TD, et al. Interleukin-6 secretion in vitro is
upcells from women with endometriosis. J Clin Endocrinol Metab, 1996;
81;1118-22.
37. Patrono C. Arachdoic acid metabolism in the ovary; biochemistry,
methodology, and physiologi. In Serra B (ed). Comprehensive
Endocrinology. The Ovary, New York:raven press, 1983; 45-56.
38. Bartosik D. Immunologic aspects of endometriosis. Seminars in
reproductive Endocrinology, 1985; 299-337.
98
39. Oosterlynck DJ, Cornillie FJ, Waer M, et al.
Immunohistochemical
characterization of leucocyte subpopulations in endometriotic lesions.
Arch Gynecol Obstet, 1993; 253;197–206.
40. Rosevear SK. Handbooks of Gynaecology Management. Endometriosis
and Chronic Pelvic Pain, Blackwell Science Ltd. Chapter, 2002; 11;2505.
41. Mclaren J, Prentice A, Charnock JD, et al. Vascular Endothelial Growth
Factor (VEGF) Concentration are Elevated in Peritoneal Fluid of
Women with Endometriosis. Hum Rep, 1996; 11:220-3.
42. Gibbs
RS,
Karlan
BY.
Danforths
Obstetrics
and
Gynecology,
Endometriosis. Lippincott Williams & Wilkins. Tenth Edition, Chapter,
2008; 41;300-50.
43. Beckmann CR, Ling FW, Barzansky BM. Obstetrics and Gynecology.
Endometriosis. Lippincott Williams & Wilkins. Sixth Edition. 2010;
Chapter (29);120-80.
44. Ilie I, Ilie R. Cytokines and endometriosis- The role of Immunological
Alterations. Biotechnology, Moleculer Biology and Nanomedicine.
Desember 2013; Vol(1);2.
45. Funamizu A, Fukui A, et al. Expression of natural Cytotoxicity receptors
on peritoneal fluid natural killer cell and cytokine production by
peritoneal fluid natural killer cell in women with endometriosis. Dept.
Obgyn, Hirosaki Univ. Graduate School of Medicine, Hirosaki, Aomari,
Japan. American Journal of Reproductive Immunology. 2014; 71;35967.
99
46. David Dong ZM, Aplin AC, and Nicosia RF. Regulation of angiogenesis
by macrophages, dendritic cells, and circulating myelomonocytic cells.
Curr Pharm Des 2009; 15;365-79.
47. Ferdazzo G, Pack M, Thomas D, et al. Distinct roles of IL-12 and IL-15
in human natural killer cell activation by dendritic cells from secondary
lymphoid organs. Proc Natl AcadSci USA, 2004; 101(47);16606-11.
48. Moretta A, Bottino C, Vitale M, et al. Activating receptors and
coreceptorrs involved in human natural killer cell-mediated cytolysis.
Annu Rev Immunol, 2001;19;197-223.
49. Van den HM, Bashar S,Junkina ME, et al. Functional adhesion of CD56
cells to decidual endothelium predicts pregnancy success in vitro
fertilization. Montreal, Canada : Paper presented at:12th International
Congress of Immunology and 4th Annual Conference of FOCIS, 2004.
50. King A. Uterine leucocytes and decidualization. Hum Reprod Update,
2006; 6(1);28-36.
51. Knopman LA, Kopcow HD, Rybalov B, et al. Human decidual natural
killer cells are a unique NK cell subset with immunomodulatory
potential. J Exp Med, 2003; 198(8);1201-12.
52. Henderson RA, Saunders PT, Mofett-King A, et al. Steroid receptor
expression in uterine natural killer cells. J Clin Endocrinol Metab, 2003;
88(1);440-49.
53. Craig A, and Witz MD. Interleukin-6; another piece of the endometriosis
cytokine puzzle. Fertility and Sterility, 2000; 73(2);212-14.
100
54. Danudjo T.
Analisis Komparasi dan
Peran
Interleukin-6
serta
Interleukin-8 dalam Zalir Peritoneal Penderita Infertilitas disertai
Endometriosis dalam Proses Apoptosis Sel Granulosa Ovarii yang
Patologis. [Disertasi]. Surabaya: Universitas Airlangga, 2003.
55. Bedaiwy MA, and Falcone T. Peritoneal fluid environment in
endometriosis, clinicopatological implication. Minerva Ginecology, 2003;
55;1-13.
56. Herington JL, Bruner KL. Immune Interaction in endometriosis expert
Rev. Clin Immunol. September 2011; 7(5);611-26.
57. Attar E. Current concepts and research in the pathogenesis of
endometriosis. 1999. Endometriosis Zone. www.OBGYN.net.com.
58. Bruner KL, Herington JL. Medical Management of endometriosis :
Emerging evidence linking inflamation to disease pathophysiology. NIH
Public Access, Minerva Ginecol, 2014; 65(2);199-213.
59. Maeda N, Izumiya C, et al. Killer Inhibitory Receptor CD158a
overexpression among natural killer cell in women with endometriosis is
undiminished by Laparoscopic Surgery and Gonadotropin releasing
hormone agonist Treatment. American Journal of Reproductive
Immunology, 2004; 51;364-72.
60. Eidukaite A., Siaurys A., Tamosiunas V. Aberrant Expression of CD 95
and CD 69 Molecules among CD 56+ Cells in Women with
Endometriosis. American Journal of Reproductive immunology; 2006;
No;55, pp;276-81.
101
61. Ahn SH, Monsanto SP, et al. Pathophysiology and Immune dysfunction
in endometriosis. Dept. Of Biomedical and Moleculer Sciences, Queen
Unv. Kingston, Biomed Research International, 2014.
62. Matsuoka S, Maeda N, et al. Expression of Inhibitory-Motif Killer
Immunoglobulin-Like Receptor, KIR2DL1, is Increased in Natural Killer
Cells from Women with Pelvic Endometriosis. American Journal of
Reproductive Immunology, 2005; Vol(53p);249-54.
63. Kim CM, Oh YJ, Cho SH, et al. Increased telomerase activity and
human telomerase reverse transcriptase mRNA expression in the
endometrium of patients with endometriosis.Hum Reprod,2007;22;8439.
64. Quenby S, Bates M, Vince G, et al. Immunohistochemical investigation
of leukocytes in pre-implantation endometrium of women with recurrent
miscarriage. J.Soc. Gynecol Invest, 1999; 6;Abstr;664.
65. Darya
HR.
Perbedaan
Kadar
IL-2
Pada
Wanita
Penderita
Endometriosis dan Non Endometriosis. Tesis Magister Obgin FK USU,
2014.
66. Laird SM, Mariee N, Wei L. Et al. Measurement of CD 56+ cells in
peripheral
blood
and
endometrium
by
flow
cytometry
and
immunohistochemical staining in situ. Human Reproduction, 2011:
Vol;26; No;6 pp;1331-7.
67. Dahlan MS. Besar sampel Dan Cara Pengambilan Sampel, dalam
Penelitian Kedokteran dan Kesehatan. Salemba Medika, 2010;
Edisi(3);19-22.
102
68. Qureshi A, Pervez S. Alred Scoring for ER Reportingand It’s Impact in
Clearly Distinguishing ER Negative From ER Positive Breast Cancer.
Department of Pathology and Laboratory Medicine: The Aga Khan
University. Journal Pakistan Medical Association, 2010; 60(5);350-53.
69. Lanier L. Natutal Killer cel Receptor signalling. Department of
Microbiology and Immunology and the cancer Research Institute.
Current opinion in Immunology, 2003; 15;308-14.
70. Orange JS, Ballas ZK. Natural Killer cells in human health and disease,
Clin Immunol, 2006; 118;1-10.
71. Disanto JP. Natural Killer cells developmental pathways: a question of
balance, Annu. Rev.Immunol, 2006; 24;257-86.
72. Lanier LL. Natural Killer cell receptor signalling, Curr.Opin. Immunol,
2006; 15;304-14.
73. Cooper MA, Fehninger TA, Turner SC, et al. Human natural killer cells:
a unique innate immunoregulatory role for the CD56 (bright) subset,
2001; Blood 97;3146-51.
74. Dorner BG, Smith HR, French AR, et al. Coordinate expression of
cytokines and chemokines by NK cells during murine cytomegalovirus
infection, J. Immunol, 2004; 172;3119-31.
75. Loza ML, Zamai L, Azzoni L, et al. Expression of type 1 (interferon
gamma) and type 2 (interleukin-13, interleukin-5) cytokine at distinct
stages of natural killer cell differentiation from progenitor cells, 2002;
Blood 99;1273-81.
103
76. Robertson MJ. Role of chemokines in the biology of natural killer
cells,J.leukoc.Biol, 2002; 71;173-83.
77. Peters PJ, Borst J, Oorschot V, et al. Cytotoxic T lymphocyte granules
are secretory lysosomes,containing both perforin and granzymes, J.
Exp. Med, 1991; 173;1099–109.
78. Winchester BG. Lysosomal membrane proteins, Eur. J. Paediatr.
Neurol. 2001; 5;11–19.
79. Fukuda
M.
Lysosomal
membrane
glycoproteins.
Structure,
biosynthesis, and intracellular trafficking, J. Biol. Chem, 1991;
266;21327–330.
80. Kannan K, Stewart RM, Bounds W, et al. Lysosome-associated
membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are
activation-dependent cell surface glycoproteins in human peripheral
blood mononuclear cells which mediate cell adhesion to vascular
endothelium, Cell. Immunol, 1996; 171;10–19.
81. Konrad KA. Lamp 1/CD107a is required for effient perforin delivery to
lytic granules and NK-cell Cytotoxyty. 2013; Blood;121.
82. Meyer C, Zizioli D, Lausmann S, et al. Mu1A adaptin-deficient mice:
lethality,
loss
of
AP-1binding
and
rerouting
of
mannose
6-
phosphatereceptors. EMBO J, 2000; 19(10);2193-203.
83. Delevoye C, Hurbain I, Tenza D, et al. AP-1 and KIF13A coordinate
endosomal sorting andpositioning during melanosome biogenesis. J
CellBiol, 2009; 187(2);247-64.
104
84. Nakagawa T, Setou M, Seog D, et al. A novelmotor, KIF13A, transports
mannose-6-phosphatereceptor
to
plasma
membrane
through
directinteraction with AP-1 complex. Cell, 2000; 103(4);569-81.
85. Bryceson YT, Rudd E, Zheng C, et al. Defectivecytotoxic lymphocyte
degranulation
in
syntaxin-11
deficient
familial
hemophagocytic
lymphohistiocytosis 4 (FHL4) patients. 2007; Blood.110(6);1906-15.
86. Ishii E, Ueda I, Shirakawa R, et al. Genetic subtypes of familial
hemophagocytic lymphohistiocytosis: correlations with clinical features
and cytotoxic T lymphocyte/natural killer cell functions. Blood. 1995;
105(9);3442-48.
87. Keefe D, Shi L, Feske S, et al. Perforin triggers a plasma membranerepair response that facilitates CTL induction of apoptosis. Immunity,
2005; 23(3);249-62.
88. Thiery J, Keefe D, Boulant S, et al. Perforin pores in the endosomal
membrane trigger the release of endocytosed granzyme B into the
cytosol of target cells. Nat Immunol, 2011; 12(8);770-77.
89. Portales P, Reynes J, Pinet V, et al. Interferonalpha restores HIVinduced alteration of naturalkiller cell perforin expression in vivo. AIDS,
2003; 17(4);495-504.
90. Rak GD, Mace EM, Banerjee PP, et al. Natural killer cell lytic granule
secretion occurs through a pervasive actin network at the immune
synapse. PloS Biol, 2011; 9(9);e1001-151.
105
91. Liu D, Martina JA, Wu XS, Hammer JA III, Long EO. Two modes of lytic
granule fusion during degranulation by natural killer cells. Immunol Cell
Biol. 2011; 89(6);728-38.
92. Moretta L, Christina B, Daniela P, et al. Human natural killer cells; their
origin,receptors and function. Eur J Immunol, 2002; 32;1205-11.
93. Oosterlynck DJ, Meuleman C, Waer M, et al. The natural killer activity
of
peritoneal fluid
lymphocytes
is
decreased
in
women
with
endometriosis. Fertil Steril, 1992; 58;290-95.
94. Vigano P, Vercellini P, Blasio D, et al. Deficient antiendometrium
lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil
Steril, 1991; 56;894-99.
95. Oosterlynck DJ, Meuleman C, Waer M, et al. The natural killer activity
of
peritoneal fluid
lymphocytes
is
decreased
in
women
with
endometriosis. Fertil Steril, 1992; 58;290-95.
96. Wilson TJ, Hertzog PJ, Angus D, et al. Decreased natural killer cell
activity in endometriosis patients:relationship to disease pathogenesis.
Fertil Steril, 1994; 62;1086-88.
97. Ho-hong N, Kuang-han C, Hsin Fu C. Peritoneal natural killer cytotoxity
and CD25+ CD3+ lymphocyte subpopulation are decreased in woman
with stage III-IV endometriosis. Human Rep, 1995; Vol;10, No;10,
pp;2671-75.
106
98. Simigliana E, Pvigano, Gaffuri B, et al. Modulation Of NK cell lytic
fuction by endometrial secretory factors:protential role in endometriosis,
American journal of reproductive immunology, 1996; Vol;36, No:5,
pp;295-300.
99. Ho HN, chao KH, Chen CH, et al. Peritoneal natural killer cytotoxity and
CD25+ CD3+ lymphocyte subpopulation are decreased in woman with
stage III-IV endometriosis. Human reprodution, 1995; Vol;10, No; 10,
pp;2671-75.
107